Table 3.
Characteristics of 128 Individuals Hospitalized with Suspected COVID-19 during Implementation of Combined POC Testing
| Characteristic | n |
|---|---|
| Male gender (%) | 42.2 |
| Median age, y (IQR) | 67 (50.8–80.0) |
| Median SpO2, % (IQR) | 96 (95–97) |
| Median fiO2 (IQR) | 0.21 (0.21–0.21) |
| Maximal additional ventilatory support | |
| Nasal cannulae | 24 |
| Face mask | 7 |
| LTOT/NIV | 4 |
| Intubation | 1 |
| Median duration of illness, days (IQR) | 2.5 (1–7) |
| NAAT+ (%) | 2 (1.6) |
| Neutralization positive (%, n = 101) | 8 (7.9) |
| COVIDIX Healthcare IgG/M+ (%)a | 6 (3.9) |
| SureScreen IgG/M+ (%)a | 6 (3.1) |
| Median lymphocyte count, ×109/L (IQR) | 1.3 (0.76–1.76) |
| Median CRP, mg/L (IQR) | 46 (15–129) |
| Comorbidities | |
| Cardiovascular disease | 44 (34.3) |
| Chronic respiratory disease | 62 (48.4) |
| Chronic kidney disease | 11 (8.6) |
| Diabetes mellitus | 24 (18.8) |
| Immune suppression | 13 (10.2) |
| Diagnosis | |
| Respiratory | 61 |
| Cardiovascular | 16 |
| Gastrointestinal | 13 |
| Genitourinary | 7 |
| Other | 30 |
| NEWS score | 2 (1–5) |
| Chest radiograph findings (n = 114) | |
| Normal | 59 |
| Indeterminate | 31 |
| Classic | 0 |
| Non-COVID-19 | 24 |
| CT findings (n = 24) | |
| Normal | 3 |
| Indeterminate | 7 |
| Classic | 1 |
| Non-COVID-19 | 13 |
LTOT, long-term oxygen therapy; NAAT, nucleic acid amplification testing; NEWS; national early warning score; NIV, non-invasive ventilation.
a
Testing done on stored serum due to finger prick test failure.